Recently, the implantable cardioverter-defibrillator (ICD) has been promoted for prevention of sudden death in hypertrophic cardiomyopathy (HCM). However, the effectiveness and appropriate selection of patients for this therapy is incompletely resolved.
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy / Maron, Bj; Spirito, P; Shen, Wk; Haas, Ts; Formisano, F; Link, Ms; Epstein, Ae; Almquist, Ak; Daubert, Jp; Lawrenz, T; Boriani, Giuseppe; Estes NA, 3rd; Favale, S; Piccininno, M; Winters, Sl; Santini, M; Betocchi, S; Arribas, F; Sherrid, Mv; Buja, G; Semsarian, C; Bruzzi, P.. - In: JAMA. - ISSN 0098-7484. - 298:4(2007), pp. 405-412. [10.1001/jama.298.4.405]
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
BORIANI, Giuseppe;
2007
Abstract
Recently, the implantable cardioverter-defibrillator (ICD) has been promoted for prevention of sudden death in hypertrophic cardiomyopathy (HCM). However, the effectiveness and appropriate selection of patients for this therapy is incompletely resolved.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
